The threat of mosquito-borne diseases, which climate change is expected to exacerbate, highlights local politics’ pivotal and understudied role in public health.
Three innovative approaches to treating infections, fighting cancer, and enhancing the body’s immune system have been selected for funding through the Cornell Center for Immunology's 2025 Multidisciplinary Seed Grants.
To satisfy the seafood needs of billions of people, offering them access to a more biodiverse array of fish creates opportunities to mix-and-match species to obtain better nutrition from smaller portions of fish.
The World Health Organization (WHO) announced Egypt has been certified malaria-free – an achievement hailed by the UN public health agency as historic.
Shannon Gleeson is a professor in Cornell University’s School of Industrial and Labor Relations. She says the push to extend immigration enforcement powers to state and local officials is increasingly targeting “safe spaces” such as schools, churches, and hospitals.
Weill Cornell Medicine has received a projected $4 million grant to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.
A study from Cornell researchers could enable a quantum leap forward in identifying and deciphering cancer-driving genetic mutations, the first step in developing effective therapeutics.
Weill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could keep thousands from accessing buprenorphine, a medication that helps people recover from addiction.
Brian Crane began as Director of the Weill Center for Cell and Molecular Biology on January 1, 2025. He is only the second Director in the History of the Weill Institute since its founding by inaugural Director Scott Emr in 2008.
